Unither Pharmaceuticals
Sterile unit-doses contract manufacturing
- B2B
- Has physical offices
- Manufacturing
- Multi-product
- Sales-led purchase
About Unither Pharmaceuticals
Worldwide leader in sterile unit-doses contract manufacturing, producing various product lines using innovative technologies for pharmaceutical companies, improving patients' lives.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001–5,000 employees
- Headquarters
- paris, Île-de-France, France
- Founded
- 1993
- Revenue
- €301MFY2025, filed accounts, INPI
- SIREN
- 492187968
- Website
- unither-pharma.com
Jobs at Unither Pharmaceuticals
- CHEF DE PROJET TRAVAUX NEUFS - ALTERNANCE (H/F)
- ANIMATEUR HSE - CDI (H/F)
- CHARGE DE DEVELOPEMENT RH - CDD (H/F)
- TECHNICIEN ASSURANCE QUALITE OPERATIONNELLE PRODUITS - CDI (H/F)
- ALTERNANT ASSURANCE QUALITE REGLEMENTAIRE (H/F)
- PREPARATEUR/TECHNICIEN DE FABRICATION - CDI (H/F)
- TECHNICIEN SUPERIEUR DE LABORATOIRE - CDI (H/F)
- RESPONSABLE ZONE DE PRODUCTION/UAP- CDI (H/F)
Unither Pharmaceuticals in the news
- Théa et Unither scellent un partenariat industriel à 140 millions d'euros en Auvergne
Théa and Unither Pharmaceuticals are investing 140 million euros in a new 20,000 m" factory in Gannat, Allier, as part of an industrial partnership.
- Théa et Unither Pharmaceuticals annoncent un partenariat industriel autour d’une nouvelle unité de production ophtalmique en Auvergne
Théa and Unither Pharmaceuticals are partnering to build a dedicated —140 million ophthalmic production unit in France, expected to produce 50 million treatments annually by 2029.
- Théa, Unither team on ophthalmic manufacturing facility
Théa Group and Unither Pharmaceuticals are investing over —140 million to build a dedicated ophthalmic manufacturing facility in France, set to be operational by 2028.
- Théa, Unither Pharmaceuticals announce industrial partnership around new ophthalmic production unit in Auvergne
Théa and Unither Pharmaceuticals announced a strategic industrial partnership for a new ophthalmic production unit in Auvergne, France, dedicated to manufacturing Théa's sterile products.
- Théa and Unither partner on 140 million euros ophthalmic manufacturing facility
Théa and Unither Pharmaceuticals are partnering to build a 140 million euro ophthalmic manufacturing facility in France.
Unither Pharmaceuticals at a glance
Unither Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in paris, Île-de-France, France.
Unither Pharmaceuticals was founded in 1993.
Unither Pharmaceuticals has 1,001–5,000 employees.
Unither Pharmaceuticals's revenue is €301M (FY2025, filed accounts, INPI).
Unither Pharmaceuticals's SIREN number is 492187968.
Unither Pharmaceuticals is hiring: 8 recent open roles, including CHEF DE PROJET TRAVAUX NEUFS - ALTERNANCE (H/F), ANIMATEUR HSE - CDI (H/F), CHARGE DE DEVELOPEMENT RH - CDD (H/F).
Selling to companies like Unither Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies